In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...

You’ve viewed 1 of 5 articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.

A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic ...

The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...

suggesting the market does not ascribe any value to their existing business or drug development pipeline, according to Jefferies analysts. "The sector needs a predictable, science-led regulator to ...

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, and accelerating timelines.

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...